关节腔内注射糖皮质激素对腰椎骨小梁密度的影响
本回顾性研究纳入50例接受至少三次中或大关节腔不溶性糖皮质激素注射且首次注射后5年内行腹部平扫CT的患者,与126例年龄性别匹配、无糖皮质激素使用史的对照比较L1-L4骨小梁密度(HU),结果显示病例与对照间及L1与规范数据间均无显著差异,累积剂量与腰椎骨小梁密度无关联。
要点
- 重复关节腔内不溶性糖皮质激素注射患者腰椎骨小梁密度与对照无显著差异。
- 累积关节腔内糖皮质激素剂量与腰椎平均骨小梁密度无关联。
- L1骨小梁密度与既定规范数据比较亦无显著差异(p > 0.2)。
核心结论
- 接受重复关节腔内不溶性糖皮质激素注射的患者与对照相比未见骨丢失风险增加。
- 累积关节腔内糖皮质激素剂量与腰椎骨小梁密度无关联。
研究设计与样本
- 回顾性研究,经IRB批准并符合HIPAA要求。
- 纳入50例(26女,24男,平均年龄69 ± 14岁)接受至少三次中或大关节腔不溶性糖皮质激素注射且首次注射后5年内行腹部平扫CT的患者。
- 纳入126例年龄和性别匹配、无既往糖皮质激素使用史且行腹部平扫CT的对照。
- 计算累积糖皮质激素剂量,测量L1至L4骨小梁密度(HU),并将L1测量值与既定规范数据比较。
- 采用双侧配对t检验或卡方检验进行组间比较,并对累积剂量与骨小梁密度行线性回归分析。
关键影像表现/征象
- 病例与对照之间L1至L4骨小梁密度无显著差异。
- L1骨小梁密度与规范数据比较无显著差异(p > 0.2)。
诊断标准与关键数值
- 骨小梁密度以HU测量,测量范围为L1至L4。
- 病例与对照间L1至L4骨小梁密度无显著差异。
- L1骨小梁密度与规范数据比较无显著差异(p > 0.2)。
- 累积关节腔内糖皮质激素剂量与腰椎平均骨小梁密度无关联(p > 0.3)。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To determine the effect of intra-articular corticosteroid injections on lumbar spine trabecular density.
MATERIALS AND METHODS: This retrospective study was IRB-approved and HIPAA-compliant. We identified 50 patients (26 F, 24 M, mean age 69 ± 14 years) who had undergone at least three medium or large joint corticosteroid injections using insoluble corticosteroids and a subsequent non-contrast abdominal CT within 5 years of the first injection. About 126 age- and sex-matched controls without history of prior corticosteroid use who had undergone non-contrast abdominal CT were identified. Cumulative corticosteroid dose was calculated. Density measurements (HU) of trabecular bone of L1 to L4 were performed, and measurements of L1 were compared to established normative data. Groups were compared using a two-sided paired t-test or a chi-squared test. Linear regression analysis between cumulative corticosteroid dose and trabecular density was performed.
RESULTS: Patients underwent a mean of 4 corticosteroid injections (range 3 to 11) with a mean cumulative corticosteroid dose of 232 ± 100 mg triamcinolone equivalent (range 120 mg to 480 mg). There was no significant difference in trabecular density of L1 to L4 between cases and controls, and there was no significant difference in trabecular density at L1 compared to normative data (p > 0.2). There was no association between cumulative intra-articular corticosteroid dose and mean lumbar trabecular density (p > 0.3).
CONCLUSION: Patients who underwent repetitive intra-articular insoluble corticosteroid injections showed no increased risk of bone loss compared to controls. Cumulative intra-articular corticosteroid dose was not associated with lumbar trabecular density.
引用
- Florance J, Hemke R, Chang CY, et al. Effects of intra-articular corticosteroid injections on lumbar trabecular density. Skeletal Radiol. 2019. PMID: 31834434. doi:10.1007/s00256-019-03362-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。